Antibiotics in the treatment of acute exacerbations of chronic bronchitis (Q34706968)

4 August 2017

1 reference

title

Antibiotics in the treatment of acute exacerbations of chronic bronchitis (English)

1 reference

4 August 2017

Lisa L Dever

1

1 reference

4 August 2017

Kavitha Shashikumar

series ordinal

2

1 reference

4 August 2017

W G Johanson

series ordinal

3

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Expert Opinion on Investigational Drugs

4 August 2017

published in

1 reference

4 August 2017

volume

11

1 reference

4 August 2017

issue

7

1 reference

4 August 2017

page(s)

911-925

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Infections with Viruses and Mycoplasma pneumoniae during Exacerbations of Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Moraxella catarrhalis: from emerging to established pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Antimicrobial resistance with Streptococcus pneumoniae in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Comparison of the fluoroquinolones based on pharmacokinetic and pharmacodynamic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Comparison of 5-day, short-course gatifloxacin therapy with 7-day gatifloxacin therapy and 10-day clarithromycin therapy for acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Advances in DNA gyrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Ketolides-telithromycin, an example of a new class of antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

ABT-773: a new ketolide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

A critical review of the fluoroquinolones: focus on respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Daily single-dose regimen and alternate-two-week triple-dose/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.11.7.911

10.1517/13543784.11.7.911

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference